RadNet, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 50.34K shares, a 15.12% decline year-over-year.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 11.96K shares, a 1095.60% increase year-over-year.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 10.19K shares, a 136.99% increase year-over-year.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 70.49K shares, a 454.07% increase from fiscal 2023.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 12.72K shares, a 49.11% decline from fiscal 2022.
- RadNet, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-06-30 | 50.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 72.48K shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 11.96K shares 10-Q · filed 2025-05-12 | 81.45K shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 10.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 70.49K shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 64.61K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 59.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 68.03K shares derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | 1.00K shares 10-Q · filed 2024-05-10 | 8.72K shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | 4.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 12.72K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 3.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2023-03-31 | 5.00K shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 25.00K shares 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |